Immucell (ICCC) Change in Acquisitions & Divestments (2010 - 2020)
Immucell's (ICCC) quarterly Change in Acquisitions & Divestments came in at $2.0 million in Q1 2020, down 73.52% on a QoQ basis from $7.4 million in Q4 2019.
Immucell (ICCC) Change in Acquisitions & Divestments (2010 - 2020) Analysis & Trends
Immucell (ICCC) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $2.0 million in Q1 2020.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $2.0 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $9.4 million (changed N/A YoY) and the FY2019 annual result came in at $7.7 million, up 2968.0% from the prior year.
- Change in Acquisitions & Divestments slipped to $2.0 million in Q1 2020, from $7.4 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $7.4 million in Q4 2019 to a low of $487000.0 in Q3 2017.
- A 4-year average of $2.2 million and a median of $2.0 million in 2020 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2016 — Change in Acquisitions & Divestments jumped 700.0% — and 2017, when it plunged 75.45%.
- Tracing ICCC's Change in Acquisitions & Divestments over 4 years: stood at $496000.0 in 2016, then declined by 1.81% to $487000.0 in 2017, then soared by 1423.61% to $7.4 million in 2019, then sank by 73.52% to $2.0 million in 2020.
- The last three Change in Acquisitions & Divestments figures came in at $2.0 million (Q1 2020), $7.4 million (Q4 2019), and $487000.0 (Q3 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immucell | 91.19 Mn | 82.33 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.97 Mn |
| Mar 31, 2020 | 1.97 Mn |
| Dec 31, 2019 | 7.42 Mn |
| Dec 31, 2019 | 7.42 Mn |
| Sep 30, 2017 | 487,000.00 |
| Sep 30, 2017 | 487,000.00 |
| Jun 30, 2017 | 2.48 Mn |
| Jun 30, 2017 | 2.48 Mn |
| Mar 31, 2017 | 2.73 Mn |
| Mar 31, 2017 | 2.73 Mn |
| Dec 31, 2016 | 496,000.00 |
| Dec 31, 2016 | 496,000.00 |
| Sep 30, 2016 | 1.98 Mn |
| Sep 30, 2016 | 1.98 Mn |
| Jun 30, 2016 | 1.49 Mn |
| Jun 30, 2016 | 1.49 Mn |
| Mar 31, 2016 | 496,000.00 |
| Mar 31, 2016 | 496,000.00 |
| Sep 30, 2015 | 248,000.00 |
| Sep 30, 2015 | 248,000.00 |